Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cannabis SuisseCSUI -42.35% 3-Year EPS without NRI Growth Rate is 28.60% as of Feb. 2026, which is 39% above its 10-year median of 20.60. The stock has 2 warning signs investors should review. Among 1,320 Real Estate companies, Cannabis Suisse ranks better than 77.65% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 28.60% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 17.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of Cannabis Suisse was 28.60% per year. The lowest was 0.00% per year. And the median was 20.60% per year.
Cannabis Suisse (OTCPK:CSUI) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Cannabis Suisse 3-Year EPS without NRI Growth Rate Related Terms
CSUI vs GMPW, AOXY, HBUV: 3-Year EPS without NRI Growth Rate Comparison
For the Real Estate Services subindustry, Cannabis Suisse's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Suisse 3-Year EPS without NRI Growth Rate vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Cannabis Suisse's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Cannabis Suisse's 3-Year EPS without NRI Growth Rate falls into.
Cannabis Suisse 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 28.60% mean?
Cannabis Suisse (CSUI) has a 3-Year EPS without NRI Growth Rate of 28.60% as of Feb. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Cannabis Suisse and its competitors. This is 39% above median its historical median of 20.60. According to the industry distribution chart, Cannabis Suisse ranks #295 out of 1320 companies in the Real Estate industry, placing it in the top 22.3%.
Is Cannabis Suisse's 3-Year EPS without NRI Growth Rate too high?
Cannabis Suisse's current 3-Year EPS without NRI Growth Rate of 28.60% is 39% above median its 10-year median of 20.60. The Real Estate industry median 3-Year EPS without NRI Growth Rate is 4.30. Cannabis Suisse's value of 28.60% is 565.1% above this industry median. Based on the distribution chart, Cannabis Suisse ranks #295 out of 1320 companies in the Real Estate industry, which is in the top quartile — a strong position relative to peers.
How does Cannabis Suisse's 3-Year EPS without NRI Growth Rate compare to GMPW and AOXY?
According to the Real Estate industry distribution chart, Cannabis Suisse ranks #295 out of 1320 companies for 3-Year EPS without NRI Growth Rate. This places Cannabis Suisse in the top 22% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 4.30. Cannabis Suisse's value of 28.60% is 565.1% above this benchmark. While the company's 10-year median is 20.60 vs. the industry median of 4.30, Cannabis Suisse has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Real Estate company?
The median 3-Year EPS without NRI Growth Rate among Real Estate companies is 4.30, based on 1,320 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Suisse's current 3-Year EPS without NRI Growth Rate of 28.60% is 565.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Cannabis Suisse and its competitors. For the Real Estate industry, the median 3-Year EPS without NRI Growth Rate is 4.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Suisse's current 3-Year EPS without NRI Growth Rate is 28.60%, which is 39% above median its own 10-year median of 20.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Suisse stock overvalued right now?
Cannabis Suisse (CSUI) has a current 3-Year EPS without NRI Growth Rate of 28.60%. The current 3-Year EPS without NRI Growth Rate is 28.60%, which is 39% above median its 10-year median of 20.60 and 565.1% above the Real Estate industry median of 4.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Cannabis Suisse (CSUI), the current 3-Year EPS without NRI Growth Rate is 28.60% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space. The company currently subleases a portion of a commercial building to a third party. its operations focus on providing flexible and efficient space solutions within the commercial real estate market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSUI has been successfully added to your 
